Hypertension and the rate of cognitive decline in patients with dementia of the Alzheimer type

Alzheimer Disease and Associated Disorders

Volumn 18, Issue 4, 2004, Pages 208-213

  Bellew, Kevin M ^a   Pigeon, Joseph G ^b   Stang, Paul E ^d   Fleischman, William ^b,c   Gardner, Russell M ^b   Baker, Wilber W ^b  

^a GLAXOSMITHKLINE   (United States)

^b VILLANOVA UNIVERSITY   (United States)

^c Department of Computing Sciences and Center of Excellence in Enterprise Technology   (United States)

^d Galt Associates Inc   (United States)

Author keywords

Cognitive decline; Hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; APOLIPOPROTEIN;

ADULT; AGE; AGED; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; DEMENTIA; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENDER; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; ANTIHYPERTENSIVE AGENTS; CASE-CONTROL STUDIES; COGNITION; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS;

EID: 11344276208     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Breteler MMB. Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging. 2000;21:153-160.
2. Elias MF, Wolf PA, D'Agostino RB, et al. Untreated blood pressure level is inversely related to cognitive functioning: the Framingham study. Am J Epidemiol. 1993;138:353-364.
3. Starr JM, Whalley LJ, Inch S, et al. Blood pressure and cognitive function in healthy old people. J Am Geriatr Soc. 1993;41:753-756.
4. Farmer ME, White LR, Abbott RD, et al. Blood pressure and cognitive performance: the Framingham study. Am J Epidemiol. 1987;126:1103-1114.
5. Scherr PA, Hebert LE, Smith LA, et al. Relation of blood pressure to cognitive function in the elderly. Am J Epidemiol. 1991;134:1303-1315.
6. van Boxtel MPJ, Gaillard C, Houx PJ, et al. Can the blood pressure predict cognitive task performance in a healthy population sample? J Hypertens. 1997;15:1069-1076.
7. Wilkie F, Eisdorfer C. Intelligence and blood pressure in the aged. Science. 1971;172:959-962.
8. Launer LJ, Masaki K, Petrovitch H, et al. The association between midlife blood pressure levels and late-life cognitive function: the Honolulu-Asia Aging study. JAMA. 1995;274:1846-1851.
9. Skoog I, Lernfelt B, Landahl S, et al. 15-year longitudinal study of blood pressure and dementia. Lancet. 1996;347:1141-1145.
10. Kilander L, Nyman H, Boberg M, et al. Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension. 1998;31:780-786.
11. Farmer ME, Kittner SJ, Abbott RD, et al. Longitudinally measured blood pressure, antihypertensive medication use, and cognitive performance: the Framingham study. J Clin Epidemiol. 1990;43:475-480.
12. Zhu L, Viitanen M, Guo Z, et al. Blood pressure reduction, cardiovascular diseases, and cognitive decline in the Mini-Mental State Examination in a community population of normal very old people: a three-year follow-up. J Clin Epidemiol. 1998;51:385-391.
13. Tzourio C, Dufouil C, Ducimetiere P, et al. Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. Neurology. 1999;53:1948-1952.
14. Snowdon DA, Greiner LH, Mortimer JA, et al. Brain infarction and the clinical expression of Alzheimer's disease: the Nun study. JAMA. 1997;277:813-817.
15. DeCarli C, Miller BL, Swan GE, et al. Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the national heart, lung, and blood institute twin study. Arch Neurol. 2001;58:643-647.
16. Knopman D, Boland LL, Mosley T, et al. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology. 2001;56:42-48.
17. Morris MC, Scherr PA, Hebert LE, et al. Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study. Arch Neurol. 2001;58:1640-1646.
18. Posner HB, Tang MX, Luchsinger J, et al. The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology. 2002;58:1175-1181.
19. Kay DWK, Bergman K. Epidemiology of mental disorders among the aged in the community. In: Birren JE, Sloan RB, eds. Handbook of Mental Health and Ageing. Englewood Cliffs, NJ: Prentice-Hall, 1980.
20. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921-923.
21. Stem RG, Mohs RC, Davidson M, et al. A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration. Am J Psychiatry. 1994;151:390-396.
22. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry. 1984;141:1356-1364.
23. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
24. Burnard B, Keman WN, Feinstein AR. Indexes and boundaries for "quantitative significance" in statistical decisions. J Clin Epidemiol. 1990;43:1273-1284.
25. Wu AW, Revicki DA, Jacobson D, et al. Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Qual Life Res. 1997;6:481-493.
26. nd ed. New York: Halstead Press, 1994:199-205.
27. Emerson JD. Combining estimates of the odds ratio: the state of the art. Stat Methods Med Res. 1994;3:157-178.
28. Di Bari M, Salti F, Nardi M, et al. Undertreatment of hypertension in community-dwelling older adults: a drug-utilization study in Dicomano, Italy. J Hypertens. 1999;17:1633-1640.
29. Haan MN, Shemanski L, Jagust WJ, et al. The role of APOE E4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA. 1999;282:40-46.
30. Kannel WB, Wolf PA, McGee DL, et al. Systolic blood pressure, arterial rigidity, and risk of stroke: the Framingham study. JAMA. 1981;245:1225-1229.